From Lab to Market: Arzeda's Manufacturing Journey
Building internal capacity for GMP-adjacent production and quality systems — lessons from scaling novel proteins without losing the speed of an R&D-first culture.
← All postsGoing from lab-scale prep to commercial output is where most biotech programs stall. This post shares the organizational and technical decisions we made to build internal manufacturing capacity — quality systems, scale-up choreography, and supplier relationships — without sacrificing R&D velocity.